Xenex Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 5 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 9.46%
- Profit Growth -20.48%
- Ebitda -197.98%
- Net Worth 3.19%
- Total Assets 5.17%
About Xenex Pharmaceuticals
Xenex Pharmaceuticals Private Limited (XPPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 February 2019 (Five years and 11 months 12 days old ). Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Amit Arya, Pravisha Arya, Vatsal Arya, and Two other members serve as directors at the Company.
Company Details
-
Location
Kolkata, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24290WB2019PTC230567
-
Company No.
230567
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Feb 2019
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Xenex Pharmaceuticals?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Arya
|
Director | 20-Feb-2019 | Current |
|
Pravisha Arya
|
Director | 06-May-2024 | Current |
|
Vatsal Arya
|
Director | 10-Jul-2021 | Current |
|
Alok Arya
|
Director | 05-Dec-2019 | Current |
|
Ashok Arya
|
Director | 10-Jul-2021 | Current |
Financial Performance of Xenex Pharmaceuticals.
Xenex Pharmaceuticals Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 9.46% increase. The company also saw a substantial fall in profitability, with a 20.48% decrease in profit. The company's net worth moved up by a moderate rise of 3.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Xenex Pharmaceuticals?
Unlock access to Xenex Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Eevee Engineering Private LimitedVatsal Arya and Ashok Arya are mutual person
-
Swabhiman Commercial Private LimitedAmit Arya and Ashok Arya are mutual person
-
Eastern Photo Services Private Limited
Amit Arya, Alok Arya and 1 more are mutual person
-
Blue Bird Imaging Private Limited.
Amit Arya, Vatsal Arya and 2 more are mutual person
-
-
Swabhiman Engineering Private Limited
Alok Arya is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Xenex Pharmaceuticals?
Unlock and access historical data on people associated with Xenex Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Xenex Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Xenex Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
